Indication
Isovaleric acidemia
Isovaleric acidemia is a rare autosomal recessive organic acid disorder caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase, which impairs the normal catabolism of the branched-chain amino acid leucine. Read more about Isovaleric acidemia
11 drugs 11 manufacturers
Drugs that treat it
Common Isovaleric acidemia therapies.
AMMONUL (sodium benzoate/sodium phenylacetate)
SODIUM PHENYLACET-SOD BENZOATE (sodium benzoate/sodium phenylacetate)
SODIUM PHENYLACET-SOD BENZOATE (sodium benzoate/sodium phenylacetate)
AMMONUL (sodium benzoate/sodium phenylacetate)
SODIUM PHENYLACET-SOD BENZOATE (sodium benzoate/sodium phenylacetate)
SODIUM PHENYLACET-SOD BENZOATE (sodium benzoate/sodium phenylacetate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonIsovaleric acidemia is a rare autosomal recessive organic acid disorder caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase, which impairs the normal catabolism of the branched-chain amino acid leucine.
This enzymatic defect predominantly manifests in neonates and young children, leading to toxic systemic accumulations of isovaleric acid and associated metabolites.
Pathophysiologically and clinically, the condition presents along a spectrum ranging from life-threatening neonatal metabolic crises to chronic intermittent decompensations typically provoked by infection, fasting, or increased protein intake.
Hallmark features include severe metabolic acidosis, hyperammonemia, vomiting, lethargy, encephalopathy, and a distinctive odor resembling sweaty feet during acute decompensation episodes.
- medlineplus.gov
Isovaleric acidemia is a rare autosomal recessive organic acid disorder caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase, which impairs the normal catabolism of the branched-chain amino acid leucine This enzymatic defect predominantly manifests in neonates and young children, leading to toxic systemic accumulations of isovaleric acid and associated metabolites Pathophysiologically and clinically, the condition presents along a spectrum ranging from life-threatening...
- nih.gov
Isovaleric acidemia is a rare autosomal recessive organic acid disorder caused by a deficiency of the mitochondrial enzyme isovaleryl-CoA dehydrogenase, which impairs the normal catabolism of the branched-chain amino acid leucine
- hrsa.gov
This enzymatic defect predominantly manifests in neonates and young children, leading to toxic systemic accumulations of isovaleric acid and associated metabolites
- nih.gov
This enzymatic defect predominantly manifests in neonates and young children, leading to toxic systemic accumulations of isovaleric acid and associated metabolites
- nih.gov
Pathophysiologically and clinically, the condition presents along a spectrum ranging from life-threatening neonatal metabolic crises to chronic intermittent decompensations typically provoked by infection, fasting, or increased protein intake
- nih.gov
Hallmark features include severe metabolic acidosis, hyperammonemia, vomiting, lethargy, encephalopathy, and a distinctive odor resembling sweaty feet during acute decompensation episodes
Personalize your experience
Follow Isovaleric acidemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.